<ARTICLE> 5 <CIK> 0000356830 <NAME> GENOME THERAPEUTICS CORP. <MULTIPLIER> 1 <PERIOD-TYPE> 9-MOS <FISCAL-YEAR-END> AUG-31-1995 <PERIOD-START> FEB-26-1995 <PERIOD-END> MAY-27-1995 <CASH> 1,599,131 <SECURITIES> 2,829,154 <RECEIVABLES> 552,264 <ALLOWANCES> (1,756) <INVENTORY> 0 <CURRENT-ASSETS> 5,090,249 <PP&E> 3,844,902 <DEPRECIATION> 2,344,600 <TOTAL-ASSETS> 7,477,598 <CURRENT-LIABILITIES> 1,532,324 <BONDS> 779,613 <COMMON> 1,278,350 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <OTHER-SE> 3,714,337 <TOTAL-LIABILITY-AND-EQUITY> 7,477,598 <SALES> 5,362,510 <TOTAL-REVENUES> 5,603,102 <CGS> 4,685,240 <TOTAL-COSTS> 4,685,240 <OTHER-EXPENSES> 2,292,061 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 39,373 <INCOME-PRETAX> (1,374,199) <INCOME-TAX> 0 <INCOME-CONTINUING> (1,374,199) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (1,374,199) <EPS-PRIMARY> (0.07) <EPS-DILUTED> 0.00